1Suppliers
0Customers
3Debt Items
0Related Chains

Provectus Biopharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
UNIVERSITY-OF-MIAMI UNIVERSITY-OF-MIAMI 92% The License Agreement grants the Company exclusive, worldwide rights to research, develop, make, use, or sell Licensed Products and/or Licensed Processes (as defined in the License Agreement) based u…

Provectus Biopharmaceuticals, Inc. Customers

No clients on recordNo downstream customers found in our database for Provectus Biopharmaceuticals, Inc..

Provectus Biopharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PVCT-DEBT Debt stack $2.8M 90% Market cache reports total debt of $2.8M.
PVCT-DEBT-11958 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
PVCT-DEBT-11957 Warrants outstanding: 4700000 90% xbrl warrant detail from xbrl 2021-12-31.

Provectus Biopharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Provectus Biopharmaceuticals, Inc..

Provectus Biopharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
PVCT-OWNER-HOME-FEDERAL-BANK-OF-TENNESSEE HOME FEDERAL BANK OF TENNESSEE 90% 13F overlay lists HOME FEDERAL BANK OF TENNESSEE as top holder; 6 tracked holders.

Provectus Biopharmaceuticals, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.